| Gene symbol | tk |
| GTO ID | GTC1174 |
| Trial ID | NCT00005057 |
| Disease | Melanoma |
| Altered gene | tk |
| Therapeutic/Target gene | Therapeutic gene |
| Therapy | Gene transfer |
| Treatment | AdV.RSV-TK |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | A Phase I Study of Intralesional Administration of an Adenovirus Vector Expressing the HSV-1 Thymidine Kinase Gene (AdV.RSV-TK) in Combination With Escalating Doses of Ganciclovir in Patients With Cutaneous Metastatic Malignant Melanoma |
| Year | 2000 |
| Country | United States |
| Company sponsor | National Human Genome Research Institute (NHGRI) |
| Other ID(s) | CDR0000067654|NCI-98-C-0140C |
| Vector information | |||||||||||
|
|||||||||||
| Cohort 1 | |||||
|
|||||